The cloud-based solutions for drug discovery, development and manufacturing market is projected to grow at a CAGR of 15.4%, predicts Roots Analysis

 The growing complexities surrounding modern therapy development initiatives have caused biopharmaceutical companies to adopt available cloud-based solutions, to not only expedite associated timelines, but also cuts down overall cost

 

Roots Analysis has announced the addition of “Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market, 2021-2030”  market report to its list of offerings.

 

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these solutions over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

 

§  A detailed assessment of the current market landscape of companies engaged in the development of cloud-based solutions for drug discovery, drug development and drug manufacturing.

§  An in depth analysis of the contemporary market trends, presented using five schematic representations.

§  A detailed company competitiveness analysis of key industry players offering cloud solutions in pharmaceutical / biotech domain taking into consideration company specific parameters.

§  Elaborate profiles of key industry players that are developing / have developed cloud-based solutions for drug discovery, drug development and drug manufacturing.

§  A detailed analysis of 57 recent global events (summits / forums / conferences / annual meetings) related to cloud-based solutions for drug discovery, drug development and drug manufacturing based on the several relevant parameters.

§  An analysis of the investments made in the period between 2012 and Q3 2020 at various stages of development in companies that are engaged in this field.

§  An analysis of the partnerships that have been inked by stakeholders in this domain, in the period between 2014 and 2020.

§  A detailed analysis featuring cost saving potential associated with the use of cloud-based solutions for drug discovery, development and manufacturing.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 

§  Type of Cloud

§  Private

§  Public

§  Hybrid

 

§  Type of Cloud Service

§  IaaS

§  PaaS

§  SaaS

 

§  Area of Application

§  Drug Discovery

§  Drug Development

§  Drug Manufacturing

 

§  End-User

§  Biotech Vendor

§  Contract Research Organizations

§  Pharmaceutical Companies

§  Others

 

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  Middle East and North Africa

§  Latin America

§  Rest of the World 

 

Transcripts of interviews held with the following senior level representatives of stakeholder companies

§  Velizar Natovski (Regional Manager North and South America, CloudSigma)

§  Paolo Colombo (Vice President Growth, InSilicoTrials)

 

Key companies covered in the report

§  Accenture

§  Alibaba Cloud                     

§  Amazon Web Services

§  ChemAxon

§  CloudSigma

§  Google

§  IBM

§  Nimbix

§  OpenEye Scientific

§  Oracle

§  Skyland Analytics

§  Veeva Systems

§  XtalPi

§  YPrime

 

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/cloud-based-solutions-in-healthcare-market.html

 

Other Recent Offerings

1.       Digital Solutions for Biomarkers Market, 2021-2030

2.     AI-based Drug Discovery Market: Focus on Deep Learning and Machine Learning, 2020-2030

3.       In Silico / Computer-Aided Drug Discovery Services Market, 2020-2030

 

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Comments

Post a Comment

Popular posts from this blog

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

    Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals   Roots Analysis is pleased to announce the publication of its recent study, titled “ Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 ” report to its list of offerings.   The report provides a detailed study on the current market landscape and future potential of biologics designed for subcutaneous administration. In addition, the study provides an in-depth analysis of the formulation technologies and drug delivery systems (focusing on large volume wearable injectors, autoinjectors, pen injectors, needle-free injectors, drug reconstitution systems, prefilled syringes and implants) that enable subcutaneous delivery of the biologic drugs. Amongst other elements, the r...
Read more

PRE-INSTALLED SINGLE-USE SENSORS FOR BIOPROCESSING-CASE STUDY

    During our research, we identified 31 pre-installed single-use sensors developed by various companies for bioprocessing. The current market landscape is predominantly characterized by the presence of large (38%) and small (37%) players. Notable examples of large players in this domain include ( in alphabetical order ) Cytiva Life Sciences (US), Hamilton (US) and Pall (US).   To Request Sample Pages -: https://www.rootsanalysis.com/reports/single-use-sensors-for-bioprocessing.html       Majority of the pre-installed single-use sensor systems are designed for both, research and biomanufacturing purposes. This is followed by those designed for only research purposes. Notable examples of products which are developed for both research and biomanufacturing applications, include ( arranged alphabetically ) ÄKTA ready XL sensor technology (Cytiva Life Sciences), Allegro™ MVP Single-Use System (Pall Corporation) and FUTURA pico (Aber Instruments)...
Read more